SCHEMBL19202337

SCHEMBL19202337

COC(=O)c1ccc(C2CC(=O)C2)cc1C(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA7 P43166 2/20 0.41
▸ CA9 Q16790 2/20 0.41
▸ CA14 Q9ULX7 2/20 0.41
▸ PDK2 Q15119 1/20 0.41
▸ PDK4 Q16654 1/20 0.41
▸ POLB P06746 3/20 0.40
▸ HTT P42858 1/20 0.40
▸ GAA P10253 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ GLA P06280 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12488195 0.88 HTT (0.44) CA12CA1CA2CA7CA9
SCHEMBL16054955 0.86 POLB (0.48) POLBGAAKDM4ESMN1; SMN2PDE4A
SCHEMBL19202175 0.86 TSHR (0.44) CA12CA1CA2CA7CA9
SCHEMBL26608440 0.86 ABL1 (0.42) CA12CA1CA2CA7CA9
SCHEMBL28721789 0.82 ACMSD (0.55) CA12CA1CA2CA7CA9
SCHEMBL19202429 0.78 HTT (0.56) CA12CA1CA2CA7CA9
SCHEMBL25303322 0.78 NR4A2 (0.59) ALDH1A1MAPTLMNARAB9AKMT2A
SCHEMBL30589687 0.78 NR4A2 (0.59) ALDH1A1MAPTLMNARAB9AKMT2A
SCHEMBL28645076 0.77 ACMSD (0.61) HTTKDM4EGLAALDH1A1MAPT
SCHEMBL14562482 0.76 GAA (0.47) POLBHTTGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071470-B FXR agonist and preparation method and application thereof 江苏豪森药业集团有限公司 2021-10-15 — — CN disclosed
WO-2017128896-A1 FXR AGONIST AND PREPARATION METHOD AND USE THEREOF 江苏豪森药业集团有限公司 2017-08-03 — — WO disclosed
Send feedback